Farid Siddiqui
farid.siddiqui@utu.fi Tykistökatu 6 Turku |
- Proteomics- and BRET- screens identify SPRY2 as a Ras effector that impacts its membrane organization (2025)
- iScience
- Elaiophylin Is a Potent Hsp90/Cdc37 Protein Interface Inhibitor with K-Ras Nanocluster Selectivity (2021)
- Biomolecules
- FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage (2021) Ras Activity and Signaling: Methods and Protocols Parkkola Hanna, Siddiqui Farid Ahmad, Oetken-Lindholm Christina, Abankwa Daniel
- Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer (2021)
- Molecular Oncology
- Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling (2021)
- Cancers
- NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane (2021)
- Life Science Alliance
- A subset of flavaglines inhibits KRAS nanoclustering and activation (2020)
- Journal of Cell Science
- PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras Activity (2020)
- ACS Omega
- Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications (2020)
- FEBS Journal
- Medium-Throughput Detection of Hsp90/Cdc37 Protein-Protein Interaction Inhibitors Using a Split Renilla Luciferase-Based Assay (2019)
- SLAS discovery
- Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1 (2017)
- Scientific Reports
UTU Research Portal